The earnings call reflected a positive sentiment with strong growth in consumables and increased profitability. However, challenges in the equipment business and tariff impacts were noted, indicating a cautious outlook for the second half of the year.

Company Guidance

During the H1 2025 conference call for Sartorius and Sartorius Stedim Biotech, the company provided several key financial metrics and guidance. Sartorius reported a 6% growth in revenue in constant currencies, with the underlying EBITDA increasing by 12% year-over-year, resulting in an EBITDA margin nearing 30%. Bioprocessing Solutions revenue grew by nearly 9% year-over-year, while Lab Products & Services saw a 4% decline in constant currency sales. The company confirmed its full-year 2025 guidance, projecting a 6% increase in constant currencies for the group, with EBITDA margins expected between 29% and 30%. Sartorius also highlighted its continued focus on innovation, mentioning new product launches and the completion of the MatTek acquisition, which will contribute to the financial results in the second half of the year. Despite uncertainties, Sartorius expressed confidence in meeting its full-year targets, supported by strong consumables demand and strategic investments in capacity and technology.

Strong Revenue Growth

Sartorius reported a revenue growth of 6% in constant currencies, driven by a strong increase in consumables sales. The Bioprocessing Solutions sales revenue grew by nearly 9% year-over-year on a constant currency basis.

Increased Profitability

The underlying EBITDA increased by 12% year-over-year, with the EBITDA margin approaching 30%. This margin expansion was driven by positive volume, product mix, and economies of scale.

Launch of New Products

Introduced new products in both bioprocessing and lab divisions, including a platform for incentivized bioprocesses and the new model of IncuCyte for real-time cell observation.

Confirmation of Full-Year Guidance

The company confirmed its full-year 2025 guidance, indicating confidence in meeting revenue and EBITDA margin targets.

Sartorius (DE:SRT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

DE:SRT Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 16, 2025	2025 (Q3)	1.07 / -	0.21	―	―	―
Jul 22, 2025	2025 (Q2)	1.30 / 1.22	0.34	258.82% (+0.88)	―	―
Apr 16, 2025	2025 (Q1)	1.18 / 1.22	1.01	20.79% (+0.21)	―	―
Jan 28, 2025	2024 (Q4)	1.13 / 1.05	0.94	11.70% (+0.11)	―	―
Oct 17, 2024	2024 (Q3)	0.86 / 0.21	0.13	61.54% (+0.08)	―	―
Jul 18, 2024	2024 (Q2)	0.98 / 0.34	1.39	-75.54% (-1.05)	―	―
Apr 18, 2024	2024 (Q1)	1.10 / 1.01	1.69	-40.24% (-0.68)	―	―
Jan 26, 2024	2023 (Q4)	0.93 / 0.94	2.25	-58.22% (-1.31)	―	―
Oct 19, 2023	2023 (Q3)	1.34 / 0.13	2.45	-94.69% (-2.32)	―	―
Jul 21, 2023	2023 (Q2)	1.46 / 1.39	2.44	-43.03% (-1.05)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

DE:SRT Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 22, 2025	€166.20	€157.40	-5.29%
Apr 16, 2025	€161.40	€176.00	+9.05%
Jan 28, 2025	€197.76	€221.56	+12.03%
Oct 17, 2024	€179.04	€209.12	+16.80%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sartorius AG (DE:SRT) report earnings?

Sartorius AG (DE:SRT) is schdueled to report earning on Oct 16, 2025, Before Open (Confirmed).

What is Sartorius AG (DE:SRT) earnings time?

Sartorius AG (DE:SRT) earnings time is at Oct 16, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Sartorius AG stock?

The P/E ratio of Sartorius is N/A.

What is DE:SRT EPS forecast?

DE:SRT EPS forecast for the fiscal quarter 2025 (Q3) is 1.07.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing